Prelude Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $308K | Buy |
38,123
+25,030
| +191% | +$202K | 0.03% | 598 |
|
|
2025
Q1 | $110K | Buy |
13,093
+2,349
| +22% | +$19.7K | 0.01% | 940 |
|
|
2024
Q4 | $85.1K | Buy |
+10,744
| New | +$85.1K | 0.01% | 978 |
|
|
2024
Q2 | – | Sell |
-10,841
| Closed | -$65.7K | – | 1108 |
|
|
2024
Q1 | $65.7K | Buy |
+10,841
| New | +$65.7K | ﹤0.01% | 1122 |
|
|
2023
Q1 | – | Sell |
-12,562
| Closed | -$25K | – | 1060 |
|
|
2022
Q4 | $25K | Buy |
+12,562
| New | +$25K | ﹤0.01% | 1023 |
|
|
2021
Q1 | – | Sell |
-338,426
| Closed | -$1.55M | – | 1079 |
|
|
2020
Q4 | $1.55M | Buy |
338,426
+64,454
| +24% | +$295K | 0.04% | 149 |
|
|
2020
Q3 | $1.06M | Buy |
273,972
+132,130
| +93% | +$513K | 0.05% | 154 |
|
|
2020
Q2 | $675K | Sell |
141,842
-75,000
| -35% | -$357K | 0.04% | 225 |
|
|
2020
Q1 | $755K | Buy |
+216,842
| New | +$755K | 0.05% | 128 |
|
|
2019
Q3 | – | Sell |
-1,300
| Closed | -$9K | – | 1171 |
|
|
2019
Q2 | $9K | Buy |
+1,300
| New | +$9K | ﹤0.01% | 1029 |
|
|
2018
Q3 | – | Sell |
-1,341
| Closed | -$22K | – | 1345 |
|
|
2018
Q2 | $22K | Buy |
+1,341
| New | +$22K | ﹤0.01% | 1064 |
|